Shockwave Medical Inc SWAV
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SWAV is a good fit for your portfolio.
News
-
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MCBC, SWAV, AIRC, MODN
-
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Macatawa Bank Corporation (Nasdaq - MCBC), Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN)
-
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SWAV, AIRC, ABIO, MODN
-
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN), ARCA biopharma, Inc. (Nasdaq - ABIO)
-
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HRT, ADTH, SWAV, AIRC
-
SWAV Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Shockwave Medical to Johnson & Johnson
-
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SWAV, AIRC, INRD
-
INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Shockwave Medical, Inc. - SWAV
Trading Information
- Previous Close Price
- $327.50
- Day Range
- $327.25–328.48
- 52-Week Range
- $157.00–331.58
- Bid/Ask
- $327.00 / $328.00
- Market Cap
- $12.28 Bil
- Volume/Avg
- 5 / 1.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- 84.27
- Price/Sales
- 17.14
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Shockwave Medical Inc is a medical device company focused on developing and commercializing novel technologies that transform the care of patients with cardiovascular disease. It establishes a new standard of care for the treatment of calcified cardiovascular disease (“atherosclerosis”) through differentiated and proprietary local delivery of sonic pressure waves, which refer to as intravascular lithotripsy (“IVL”). Its IVL technology is a minimally invasive, easy-to-use, and safe way to improve outcomes for patients with calcified cardiovascular disease also IVL catheters enables delivery of IVL therapy to diseased vasculature throughout the body for calcium modification.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 1,468
- Website
- https://www.shockwavemedical.com
Comparables
Valuation
|
Metric
|
SWAV
|
SIBN
|
ATEC
|
|---|---|---|---|
Price/Earnings (Normalized) | 84.27 | — | — |
Price/Book Value | 18.12 | 3.68 | 22.00 |
Price/Sales | 17.14 | 4.23 | 3.10 |
Price/Cash Flow | 52.16 | — | — |
Price/Earnings
SWAV
SIBN
ATEC
Financial Strength
|
Metric
|
SWAV
|
SIBN
|
ATEC
|
|---|---|---|---|
Quick Ratio | 10.61 | 8.01 | 1.86 |
Current Ratio | 11.76 | 9.01 | 2.86 |
Interest Coverage | 26.24 | −13.52 | −10.23 |
Quick Ratio
SWAV
SIBN
ATEC
Profitability
|
Metric
|
SWAV
|
SIBN
|
ATEC
|
|---|---|---|---|
Return on Assets (Normalized) | 19.87% | −8.97% | −9.89% |
Return on Equity (Normalized) | 35.18% | −12.61% | — |
Return on Invested Capital (Normalized) | 22.54% | −11.78% | −9.94% |
Return on Assets
SWAV
SIBN
ATEC
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Xzrgycmh | Xrjqqn | $182.7 Bil | |
SYK
| Stryker Corp | Tdzxthfvwc | Pyts | $124.6 Bil | |
MDT
| Medtronic PLC | Yptqmyxhx | Wlyfcj | $105.2 Bil | |
BSX
| Boston Scientific Corp | Zvwgbpnd | Wckxczj | $99.1 Bil | |
EW
| Edwards Lifesciences Corp | Nsrzlznq | Npfxnn | $52.0 Bil | |
DXCM
| DexCom Inc | Mlbfwcttj | Fybbs | $51.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Srzccyzf | Gnmm | $24.5 Bil | |
ALGN
| Align Technology Inc | Zptyxffk | Xnspmf | $22.7 Bil | |
PHG
| Koninklijke Philips NV ADR | Wscrywwj | Yztdgj | $18.3 Bil | |
PODD
| Insulet Corp | Dmmvxqxpw | Gmwkhj | $11.6 Bil |